Edward Hurwitz
CIK 1211840 · last filed 2026-06-09
Edward Hurwitz is a corporate insider who has filed 50 SEC Form 4 insider transactions across 6 companies since 2009. The most recent filing, for DYN, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.7M across reported positions. 16 SEC filings were submitted jointly with ALTA BIOPHARMA PARTNERS III LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 91,081 | $15.35 | $1.40M | $0 | 7 | 2026-06-09 |
| MGNX | Director | 1,752,820 | $3.59 | $6.29M | -$11.19M | 18 | 2026-05-20 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 0 | $0.39 | $0 | $0 | 12 | 2022-12-01 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | Director | 45,837 | $15.96 | $731.6K | $8.69M | 2 | 2014-02-05 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | 582 | $18.62 | $10.8K | -$4.49M | 9 | 2013-07-02 |
| Molecular Templates, Inc. (THLD) Delisted | 139,693 | — | — | $4.00M | 1 | 2009-10-06 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | DYN | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | MGNX | Mixed | +3,750 | $0 | EDGAR |
| 2025-06-03 | DYN | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | MGNX | Mixed | +6,500 | $0 | EDGAR |
| 2024-05-24 | DYN | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | MGNX | Exer (M) | +4,500 | $0 | EDGAR |
| 2023-09-01 | MGNX | Buy (P) | +15,000 | $73.7K | EDGAR |
| 2023-06-02 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | DYN | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.